Shares of Cardio Diagnostics Holdings, Inc. (CDIO), an artificial intelligence-powered precision cardiovascular medicine company, are rising nearly 150% Tuesday morning following the launch of PrecisionCHD, a blood test for the early detection of coronary heart disease.
PrecisionCHD, a non-invasive test detects coronary heart disease with better than 75% sensitivity in both men and women. the company said.
CDIO is at $3.15 currently. It has traded in the range of $0.79-$10.25 in the last 1 year.
Source: Read Full Article
Lates News:
-
Elon Musk’s $1 Billion Bitcoin Sale From Tesla’s Bag Is A Drop In The Ocean – Binance Chief CZ
-
$BTC Recent Sell-off 'Almost Exclusively' Carried out by Short-Term Holders, Says Coinbase Research
-
Pfizer Boosts FY22 Outlook As Q3 Results Top Estimates
-
Jim Cramer Calls $BTC ‘A Strange Animal’, Says ‘I Would Sell My Bitcoin Right Into This Rally’
-
Markets Muted Ahead Of Inflation Update